Deep Track Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.4M Buy
+200,000
New +$32.1M 0.46% 50
2023
Q4
– Sell
-300,000
Closed -$33.8M – 71
2023
Q3
$33.8M Buy
+300,000
New +$31.6M 1.3% 28

Other funds holding NBIX

Deep Track Capital's NBIX Position: Q3 2026 in Review

Deep Track Capital opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 200,000 shares worth $28.4M. The stake represents 0.46% of the portfolio and ranks #50 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in NBIX as recently as Q3 2023.

Deep Track Capital first reported a position in NBIX in Q3 2023 and has held it in 2 quarters since. The position peaked at $33.8M in Q3 2023. 766 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Deep Track Capital held 200,000 shares of Neurocrine Biosciences worth $28.4M as of Q3 2026.
  • Neurocrine Biosciences was a new Deep Track Capital position in Q3 2026.
  • Neurocrine Biosciences made up 0.46% of Deep Track Capital's portfolio in Q3 2026, its #50 holding.
  • Deep Track Capital first reported a position in Neurocrine Biosciences in Q3 2023 and has held it in 2 quarters since.
  • Deep Track Capital's Neurocrine Biosciences position peaked at $33.8M in Q3 2023.
  • 766 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Deep Track Capital's 13F filing for Q3 2026, filed 16 Nov 2026.